Personalized Genomic Testing for Disease Risk

Number 527

ABSTRACT: Advances in genetic technologies have led to the identification of hundreds of single nucleotide polymorphisms that are associated with a variety of complex diseases, including cancer, diab...

Opioid Abuse, Dependence, and Addiction in Pregnancy

Number 524

ABSTRACT: Opioid use in pregnancy is not uncommon, and the use of illicit opioids during pregnancy is associated with an increased risk of adverse outcomes. The current standard of care for pregnant ...

Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination

Number 521

(Replaces No. 438, August 2009)

ABSTRACT: In light of the recent increased incidence of pertussis in the United States, in 2011, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices approved...

Disclosure and Discussion of Adverse Events

Number 520

(Replaces No. 380, October 2007)

ABSTRACT: Disclosure and discussion of adverse events in health care with the patient are morally and ethically necessary to achieve the optimal goal of respecting patient autonomy. Improving the dis...

Intimate Partner Violence

Number 518

ABSTRACT: Intimate partner violence (IPV) is a significant yet preventable public health problem that affects millions of women regardless of age, economic status, race, religion, ethnicity, sexual o...

Emergent Therapy for Acute-Onset Severe Hypertension with Preeclampsia and Eclampsia

Number 514

ABSTRACT: Acute-onset, persistent (lasting 15 minutes or more), severe systolic (greater than or equal to 160 mm Hg) or severe diastolic hypertension (greater than or equal to 110 mm Hg) or both in p...

Health Care for Pregnant and Postpartum Incarcerated Women and Adolescent Females

Number 511

ABSTRACT: Clinicians who provide care for incarcerated women should be aware of the special health care needs of pregnant incarcerated women and the specific issues related to the use of restraints d...

Understanding and Using the US Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

ABSTRACT: The 2010 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) issued by the Centers for Disease Control and Prevention gives comprehensive, evidence-based guidance to clinicia...

Screening and Diagnosis of Gestational Diabetes Mellitus

Number 504

Abstract: Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance that begins or is first recognized during pregnancy, is associated with increased maternal, fetal, and neonatal risk...

Maternal-Fetal Intervention and Fetal Care Centers

Number 501

ABSTRACT: The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention. Although fetal interventions are driven by a beneficence-based motivation to ...

Adult Manifestations of Childhood Sexual Abuse

Number 498

(Reaffirmed 2013)

ABSTRACT: Long-term effects of childhood sexual abuse are varied, complex, and often devastating. Many obstetrician-gynecologists knowingly or unknowingly provide care to abuse survivors and should s...

At-Risk Drinking and Alcohol Dependence - Obstetric and Gynecologic Implications

Number 496

(Reaffirmed 2013)

ABSTRACT: Compared with men, at-risk alcohol use by women has a disproportionate effect on their health and lives, including reproductive function and pregnancy outcomes. Obstetrician–gynecologists h...

Vitamin D - Screening and Supplementation During Pregnancy

Number 495

ABSTRACT: During pregnancy, severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis, congenital rickets, and fractures in the newborn. At...

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

Abstract: The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed. As with all patients, antibiotics should be prescribed for pr...

Hepatitis B Hepatitis C and Human Immunodeficiency Virus Infections in Obstetrician - Gynecologists

Number 489

(Replaces No. 332, May 2006)

ABSTRACT: In the health care setting, bloodborne pathogens such as the hepatitis B virus (HBV), hepatitis C virus, and human immunodeficiency virus (HIV) may be transmitted from infected patients to ...

Preparing for Clinical Emergencies in Obstetrics and Gynecology

Number 487

(Replaces No. 353, December 2006)

ABSTRACT: Patient care emergencies may periodically occur at any time in any setting, particularly the inpatient setting. To respond to these emergencies, it is important that obstetrician–gynecologi...

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Replaces No. 325, December 2005)

ABSTRACT: In 2001, the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cyst...

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Reaffirmed 2013, Replaces No. 279, December 2002)

ABSTRACT: In 2010, the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease. Although universal screening at 35–37 weeks of ...

Newborn Screening

Number 481

(Replaces No. 393, December 2007)

ABSTRACT: Newborn screening programs are mandatory, state-based public health programs. They provide newborns in the United States with presymptomatic testing and necessary follow-up care for a varie...

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT: Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country. Methamphetamine use in preg...